Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 7.880 SEK | +0.13% |
|
-2.23% | +47.57% |
| Market Cap | 3.66B 375M 325M 307M 279M 522M 35.94B 525M 1.42B 18.23B 1.41B 1.38B 58.11B | P/E 2026 * |
-9.06x | P/E 2027 * | -17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.11B 318M 276M 261M 237M 444M 30.53B 446M 1.2B 15.49B 1.2B 1.17B 49.36B | EV / Sales 2026 * |
5.65x | EV / Sales 2027 * | 10.1x |
| Free-Float |
37.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| EGTX | Delayed | |
CBOE
| Real-time | ||
|
London S.E.
| 0ABW | Delayed | |
|
OTC Markets
| PDPH.F | Delayed | |
|
Börse Stuttgart
| P0F | Delayed | |
|
Deutsche Boerse AG
| P0F | Delayed | |
|
CBOE
| 0ABW | Real-time | |
|
Boerse Muenchen
| P0F | Real-time |
Last Transcript: Egetis Therapeutics AB
| 1 day | +0.13% | ||
| 1 week | -2.23% | ||
| Current month | +0.38% | ||
| 1 month | +10.06% | ||
| 3 months | +50.10% | ||
| 6 months | +46.47% | ||
| Current year | +47.57% |
| 1 week | 7.8 |  | 8.18 |
| 1 month | 6.73 | | 8.2 |
| Current year | 4.23 | | 8.2 |
| 1 year | 3.62 | | 8.2 |
| 3 years | 3.02 | | 9.3 |
| 5 years | 3 | | 9.3 |
| 10 years | 3 | | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
Behshad Sheldon
BRD | Director/Board Member | 63 | 2022-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | Executive/Senior Manager | -594 | 0.0001% | ||
| 8/31/26 | Exercice | Chief Financial Officer | 1,099 | 0.0002% | ||
| 8/31/26 | Buy | Chief Operating Officer | 1,099 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -2.23% | +52.12% | +79.70% | 374M | |
| +0.66% | +1.83% | +47.32% | +97.63% | 69.18B | |
| -1.19% | -1.92% | +34.57% | +73.08% | 62B | |
| +2.22% | -4.83% | -15.32% | +360.65% | 26.19B | |
| +2.02% | +7.26% | +29.91% | +16.86% | 25.75B | |
| -0.89% | -2.34% | -3.46% | -15.24% | 24.29B | |
| +2.84% | +3.61% | +24.60% | -17.13% | 19.84B | |
| 0.00% | -10.41% | +171.96% | +298.75% | 15.65B | |
| -0.21% | -2.66% | +45.07% | +160.34% | 14.1B | |
| +0.26% | -3.04% | -10.07% | +454.22% | 14.09B | |
| Average | +0.54% | -1.57% | +37.67% | +150.89% | 27.15B | |
| Weighted average by Cap. | +0.41% | -1.24% | +34.61% | +124.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 551M 56.35M 48.84M 46.16M 41.91M 78.54M 5.41B 79.01M 213M 2.74B 212M 207M 8.74B | 328M 33.52M 29.05M 27.46M 24.93M 46.72M 3.22B 47M 127M 1.63B 126M 123M 5.2B |
| Net income | 161M 16.49M 14.29M 13.51M 12.26M 22.98M 1.58B 23.12M 62.31M 802M 61.95M 60.58M 2.56B | -134M -13.73M -11.9M -11.25M -10.21M -19.13M -1.32B -19.25M -51.87M -668M -51.57M -50.43M -2.13B |
| Net Debt | -552M -56.42M -48.9M -46.22M -41.96M -78.64M -5.41B -79.11M -213M -2.75B -212M -207M -8.75B | -353M -36.11M -31.29M -29.57M -26.85M -50.32M -3.46B -50.62M -136M -1.76B -136M -133M -5.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | SEK 7.880 | +0.13% | 529,098 |
| 26-09-15 | SEK 7.870 | -1.13% | 689,813 |
| 26-09-14 | SEK 7.960 | +0.89% | 524,614 |
| 26-09-11 | SEK 7.890 | -1.99% | 505,531 |
| 26-09-10 | SEK 8.050 | -0.12% | 1,173,584 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Select your edition
All financial news and data tailored to specific country editions
